Structural and Regulatory Elements of HCV NS5B Polymerase – β-Loop and C-Terminal Tail – Are Required for Activity of Allosteric Thumb Site II Inhibitors

• Sarah E. Boyce,

  Current address: Schrödinger, New York, New York, United States of America

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Neeraj Tirunagari,

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Anita Niedziela-Majka,

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Jason Perry,

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Melanie Wong,

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Elaine Kan,

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Leanna Lagpacan,

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Ona Barauskas,

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Magdeleine Hung,

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Martijn Fenaux,

  Current address: Novartis Institute for BioMedical Research, Emeryville, California, United States of America

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Todd Appleby,

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• William J. Watkins,

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Uli Schmitz,

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯
• Roman Sakowicz

  * E-mail: roman.sakowicz@gilead.com

  Affiliation Gilead Sciences Inc., Foster City, California, United States of America

  ⨯